Raben David

Chief Medical Officer

Raben David has filed 6 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Apr 28, 2026.

On the most recent filing, Raben David is listed as Chief Medical Officer at Bicara Therapeutics Inc. Inside the rolling window, Raben David reported no open-market purchases and 6 open-market sales totaling $741K in BCAX. The largest disclosed transaction in the window is a sale of 16,300 BCAX shares on Mar 4, 2026, worth $302K.

Companies traded

Other insiders at BCAX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$741K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BCAXSale$126KApr 28SEC ↗
BCAXSale$104KMar 26SEC ↗
BCAXSale$4KMar 5SEC ↗
BCAXSale$302KMar 5SEC ↗
BCAXSale$101KNov 25SEC ↗
BCAXSale$104KNov 25SEC ↗
Showing 1–6 of 6
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 9, 2025BCAXSale$406K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Raben David made?

Raben David has filed 6 SEC Form 4 filings (17 transaction rows) across 1 company since 2025.

Which companies does Raben David trade?

Raben David has filed SEC Form 4 disclosures for 1 company, including BCAX.

When was Raben David's most recent SEC Form 4 filing?

Raben David's most recent SEC Form 4 filing on Tracefour is dated Apr 28, 2026.

What is Raben David's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Raben David is listed as Chief Medical Officer.

What is Raben David's total buy and sell value in the current window?

Inside the rolling retention window, Raben David bought $0 and sold $741K based on SEC Form 4 filings.

What was Raben David's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 16,300 BCAX shares on 2026-03-04, worth $302K, per SEC Form 4 filings.